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Abstract
Emergency department admissions due to implantable cardioverter-defibrillator (ICD) shocks 
constitute  an  important  patient  group.  The  correct  evaluation  includes  a  review of  system 
integrity  and  a  careful  analysis  of  stored  intracardiac  electrograms.  We  present  a  patient 
admitted with a single ICD discharge due to an episode of sustained monomorphic ventricular 
tachycardia,  and  an  unexpected  finding.                                         
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Introduction
Inappropriate implantable cardioverter defibrillator (ICD) shocks are in most cases due to a 
supraventricular  tachyarrhythmia  misclassified  by the device.  Other  causes  of  inappropriate 
discharges  include  T wave oversensing,  atrial  far-field  sensing,  double  or  triple  sensing of 
ventricular  signals,  myopotentials,  lead  or  connector  block  failure  or  electromagnetic 
interferences.  A careful  review of  the  stored  intracardiac  electrograms  during  the  episodes 
usually identifies the underlying cause. However, in certain situations this may be difficult due 
to the presence of complex device programmed algorithms. Therefore a correct knowledge and 
recognition of these algorithms and stored episodes is critical for a proper understanding of the 
ICD function and when making subsequent management decisions. We report a patient who 
presented  with  a  single  ICD  discharge  due  to  a  non-syncopal  sustained  monomorphic 
ventricular  tachycardia,  and an  unexpected  finding.                                     
Case  Presentation                                   
A 73-year-old man with a history of ischemic cardiomyopathy, severely reduced left ventricular 
ejection fraction and renal dysfunction, underwent a dual chamber ICD implant for secondary 
prevention. Five years later a system replacement (Maximo II DR D264DRM, Medtronic Inc., 
Minneapolis, MN, USA), due to a delayed device-related infection, was carried out. The new 
implanted  device  was programmed with three  detection  zones  and corresponding therapies: 
ventricular  tachycardia  (VT-1)  detection  at  350 ms  with  antitachycardia  pacing (ATP)  and 
cardioversion (CV), fast ventricular tachycardia (VT-2) detection at 310 ms with ATP and CV 
and ventricular fibrillation (VF) detection at 260 ms with ATP during charging and 
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defibrillation. Two months later, the patient was admitted to the emergency department due to a 
single nonsyncopal ICD shock. The stored intracardiac electrogram (Figure 1) showed a single 
arrhythmic episode classified as VF consisting of a regular monomorphic tachycardia with a 
mean cycle length of 250 ms with clearly different electrograms as compared with those in 
sinus  rhythm,  as  well  as  atrio-ventricular  dissociation,  confirming  true  ventricular 
tachyarrhythmia.  The  ICD  interrogation  revealed  no  abnormal  parameters  for  sensing  and 
pacing. Antitachycardia pacing during charging correctly terminated the arrhythmia, achieving 
stable sinus rhythm. However, the device delivered a high-energy shock after completion of 
capacitors charging. Is the device functioning correctly?
Figure 1: Ventricular tachycardia with a mean cycle length of 250 ms occurring within the VF zone, is initially 
treated by programmed ATP during charging, which correctly terminates the arrhythmia. At the end of charging, 
stable  sinus  rhythm can  be  identified.  After  VR,  due  to  T wave oversensing,  the  next  two RR intervals  are 
incorrectly  classified  in  VT  detection  interval  +  60  ms  range  and  a  shock  is  delivered.                
Discussion
Antitachycardia  pacing during charging is a useful  feature for reducing high-energy shocks 
delivered by an ICD when the patient suffer an episode of sustained ventricular tachycardia 
with  a  cycle  length  within  VF  zone.  Programming  this  algorithm,  ventricular  tachycardia 
episodes longer than 240 ms, occurring within the VF zone, may be terminated successfully in 
69% of cases [1], improving quality of life by decreasing the number of painful termination 
events [2]. ATP during charging is a programmable feature that consists of a burst (nominal) of 
eight (nominal)  impulses at 88% (nominal)  of the tachycardia cycle length.  This therapy is 
applied while the capacitors are charging, when the device detects a ventricular tachycardia 
within  the  VF zone.  If  any one of  the  last  eight  RR intervals  is  shorter  than  programmed 
interval (nominal 240 ms), the device delivers a shock. By contrast, ATP is delivered if all of 
the last eight RR intervals are longer than or equal to the ATP cut off rate (nominal; 240 ms). 
Once the charge is enabled on the device after the delivery of the ATP, a confirmation window 
of the tachycardia is carried out by monitoring the ventricular rate for the next five beats. This 
confirmation works by analyzing cycle length for the beats after the charging is enabled (in 
contrast, if ATP during charging is not programmed on, confirmation window is carried out 
when the capacitors starts charging). If four of the last five analyzed beats have a cycle length 
longer than the VT-1 (or VF if VT-1 and fast ventricular tachycardia are off)  detection interval 
plus 60 ms, shock is aborted. Otherwise, the device delivers a high-energy shock [3]. Certain 
delays  during confirmation  window up to shock have not  been related  with an increase  of 
symptoms.  In the present  case,  a  ventricular  tachycardia  with a  cycle  length  of  250 ms is 
detected within the VF zone (Figure 1). The device applies a burst of eight impulses with a 
cycle length of 220 ms, with successful termination of the tachycardia. Subsequently, when the 
capacitor terminates to charge (Figure 1, CE on marker channel), though a stable sinus rhythm 
is observed in the electrograms, oversensing of the T wave results in two of the last three RR 
intervals falling within the VT-1 + 60 ms interval resulting in false confirmation of ongoing 
tachycardia  and delivery  of shock.                                                        
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The first event after charging is enabled that is due to T wave oversensing and is sensed as 
ventricular refractory (Figure 1. VR), and is ignored. The next event is a true event followed 
again by oversensed T wave, thus the two intervals fall in the tachycardia detection interval + 
60 ms range. The device assumes that the tachycardia is ongoing and subsequently delivers a 
shock.  
New ICDs try to  avoid this  problem by an implementing  algorithm called confirmation  +. 
When the algorithm is programmed on the confirmation window starts just after ATP delivery. 
The rate considered for analysis is based on the cycle length of the detected arrhythmia, instead 
of the programmed cut-off zones. If four of the last five analyzed RR intervals have a cycle 
length longer than the cycle length of the detected tachycardia plus 60 ms, shock is aborted. 
The rhythm cycle length is calculated considering the six RR intervals immediately prior to 
detection, dropping the minimum and maximum intervals and taking the mean of the remaining 
four.  Based  on  these  criteria,  the  device  classifies  the  rhythm  as  ongoing  or  terminated. 
Additional criteria may be applied depending on the detection zone and whether the rhythm is 
polymorphic.  
On the  other  hand,  possible  causes  for  T-wave oversensing  include  diminution  of  R-wave 
amplitude and relative or dynamic gain in the T-wave amplitude, progressive cardiomyopathy, 
electrolyte abnormalities (such as hyperkalaemia), medications, injury current-related increase 
in the T-wave voltage, or changes in the sympathetic tone. Newer generation devices have an 
interesting  feature  called  T-wave  Discrimination that  try  to  reduce  the  potential  to  deliver 
inappropriate therapy for high rates that are attributable to T-wave oversensing. When VT or 
VF  is  suspected,  T-Wave  Discrimination applies  amplitude,  rate,  and  pattern  criteria  to 
determine  if  both  R-waves  and  T-waves  are  being  sensed.  If  both  are  sensed,  VT or  VF 
detection is withheld. If only R-waves are sensed, VT or VF detection occurs. This algorithm is 
applied  on  initial  detection  and  on  redetection.                                  
This case reflects the importance of a systematic review of the stored intracardiac electrograms 
and a thorough knowledge of the device programmed algorithms in patients with an ICD in 
order to correctly interpret the findings observed and to reprogramming device algorithms when 
needed.
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